Evidence map›Paper›PMID 40062657›Full record

ArticleTurkish journal of obstetrics and gynecology2025

Effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on oocyte count over the punctured follicle number in consecutive two cycles: A comparative study.

Özge Karaosmanoğlu, Nazlı Albayrak, Ayşen Yücetürk, Bülent Tıraş

Abstract read
In one paragraph

Article in Turkish journal of obstetrics and gynecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Özge KaraosmanoğluAcıbadem Maslak Hospital, In Vitro Fertilization Unit, İstanbul, Türkiye.ORCID 0000-0001-8184-4747
Nazlı AlbayrakCornell University, Department of Public Health, Ithaca, New York, U.S.A.ORCID 0000-0002-3405-028X
Ayşen YücetürkAcıbadem Maslak Hospital, In Vitro Fertilization Unit, İstanbul, Türkiye.ORCID 0000-0002-7065-6588
Bülent TıraşAcıbadem University Faculty of Medicine, Department of Obstetrics and Gynecology, İstanbul, Türkiye.ORCID 0000-0003-2297-3332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Controlled ovarian hyperstimulation plays a critical role in in vitro fertilization (IVF) success. However, premature luteinization and variations in oocyte yield can impact IVF outcomes. This comparative study aims to investigate the effects of gonadotropin releasing hormone antagonist (GNRHant) and oral progestin-primed protocol on the oocyte count over the punctured follicle number in the same patient group undergoing consecutive IVF cycles. Materials and Methods: Forty-nine patients undergoing IVF were enrolled in this comparative study. Each participant underwent two consecutive IVF cycles. In the first cycle, GNRHant protocol was used. In the second cycle, the OPP protocol was used. The number of punctured follicles and oocytes retrieved was recorded and compared between the two cycles for each patient. Results: The ratio of oocyte count per punctured follicle number was higher in the OPP group compared to the GNRHant group, without clinical significance (p>0.05). In the OPP, the ratio of oocytes retrieved over the punctured follicle number was 0.90±0.28; in the GNRHant group, it was recorded as 0.94±0.36, and the differences between the ratios were statistically insignificant. Conclusion: Oocyte yield is a critical determinant of IVF success, and it can be influenced by various factors, including premature luteinization and follicular development. The use of GNRHant and OPP is known to prevent premature luteinization and improve follicular synchronization. This study demonstrates that neither of the protocols is superior in the success of oocyte retrieval over the punctured follicle count. Further research with larger sample sizes and randomized controlled trials is warranted to validate these results, and optimize clinical application of this combined protocol in IVF treatments.

Indexed as

controlled ovarian hyperstimulationgonadotropin releasing hormone antagonistInfertilityoral progestin-primed protocol

Identifiers

PMID40062657
PMCPMC11894775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.